Our multivariate data suggest that Lp-PLA2 may help as a potential biomarker for discriminating between the two diseases, with this ability apparently not influenced by classical cardiometabolic risk factors such as dyslipidemia, diabetes, and history of previous CVD [40,41,42]. The gene discussed is PLA2G7; the disease is diabetes mellitus.